NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
This grant funds research aimed at developing therapeutics for eye diseases.
About this program
The NEI Translational Research Program for Therapeutics supports innovative research projects that aim to develop new therapeutic approaches for treating eye diseases. This program is designed for researchers who are focused on translating basic scientific discoveries into clinical applications that can improve patient outcomes. The funding is intended to facilitate the transition from laboratory research to practical therapeutic solutions, ultimately benefiting individuals affected by vision impairment and blindness. Eligible applicants include academic institutions, nonprofit organizations, and other research entities that have the capacity to conduct translational research. The program encourages collaboration among researchers, clinicians, and industry partners to enhance the development of effective therapies. Projects funded under this program should demonstrate a clear pathway to clinical application and address significant unmet needs in the field of ophthalmology.
Eligibility
Academic institutions, nonprofit organizations, and research entities focused on eye disease therapeutics.
Requirements
- Research must focus on developing therapeutics for eye diseases
- Collaboration with clinicians or industry partners is encouraged